Xxera/openscience/retractions

Record #64826

Development of novel anti-Kv 11.1 antibody-conjugated PEG–TiO2 nanoparticles for targeting pancreatic ductal adenocarcinoma cells

Angelica Sette, Jolanda Spadavecchia, Jessem Landoulsi, Sandra Casale, Bernard Haye, Olivia Crociani, Annarosa Arcangeli

Journal

Journal of Nanoparticle Research

Publisher

Springer - Nature Publishing Group

Original paper date

Nov 16, 2013

Original DOI

10.1007/s11051-013-2111-6

Country

🇫🇷 France · 🇮🇹 Italy

Institution

Section of Internal Medicine, Department of Experimental and Clinical Medicine, University of Florence, Viale GB Morgagni 50, 50134, Florence, Italy · Laboratoire de Réactivité de Surface, UMR CNRS 7197, Université Pierre & Marie Curie-Paris VI, Site d’Ivry-Le Raphaël, 94200, Ivry-sur-Seine, France · Chimie de la Matière Condensée de Paris, Collège de France, Université Pierre & Marie Curie – Paris VI, 11 place Marcelin Berthelot, Paris, France · DI.V.A.L. Toscana srl, Via Madonna del Piano 6, 50019, Sesto Fiorentino (FI), Italy

Open access

No

Article type

Research Article

Broad categories

(BLS) Biochemistry (BLS) Biology - Cellular (BLS) Microbiology (PHY) Nanotechnology

Notes from Retraction Watch

see aslo: https://pubpeer.com/publications/90304346FB0E8D3B1EFF78FAE11256 and https://mis.cnrs.fr/wp-content/uploads/2025/05/Recommandations.pdf

Citation lifecycle

How this paper is being cited

Pre-retraction

31

Same day

0

Post-retraction

1

% post-retraction

3.1%

~2.7 citations/yr before retraction · ~0.6 citations/yr after

— citing papers

Who is still citing this work

Loading…